Live Twitter Chat and Webinar: PrEP Demo Project for Black MSM
HIV disproportionately affects men who have sex with men (MSM), and MSM of color in particular. African-American men accounted for the largest estimated proportion of new HIV infections among MSM in 2011, according to data from the Centers for Disease Control and Prevention.
To better understand whether and how PrEP—a daily pill to avert HIV infection—can be an effective tool to help African-American MSM avoid infection, the HIV Prevention Trials Network (HPTN) is launching a demonstration project in three U.S. cities.
The study, HPTN 073, will address whether African-American MSM will be interested in PrEP (and why or why not) and what barriers hinder access to or use of PrEP, as well as safety, efficacy, and factors that contribute to adherence and any changes in sexual behaviors. HPTN 073 is currently recruiting and aims to enroll a total of 225 volunteers in Chapel Hill, Los Angeles, and Washington, DC.
Want to learn more? Join the live Twitter chat and register for next Wednesday’s webinar to get the details, ask questions, and hear perspectives from the project team. The live Twitter chat begins Wednesday, August 14, at 1:00 p.m. Eastern Time; see the image below (courtesy of HPTN) or click here to learn more.
The webinar discussion will be moderated by Greg Millett, Senior Policy Advisor in the Office of National AIDS Policy. Presenters will include Myron Cohen, HPTN co-principal investigator; HPTN 073 protocol chairs Darrell Wheeler and Sheldon Fields; Christopher Chauncey Watson, chair of the HPTN Black Caucus and director of the George Washington University clinical research site; and Jonathan Paul Lucas, HPTN 073 community project manager.
The webinar invitation is excerpted below; click here to register.
My Life. My Health. My Choice.
Wednesday, August 14, 2013
2:00–3:30 p.m. Eastern Time
Please join the HIV Prevention Trials Network (HPTN) as we celebrate the launch of a novel PrEP study for Black men who have sex with men (BMSM). The new study, HPTN 073, is a demonstration project designed to see if BMSM are willing to use Truvada for PrEP.
During the webinar you will be provided with:
- An overview of HPTN’s research agenda, including insight into HPTN’s engagement of Black men and women at all levels of the research process,
- Insight into prior HPTN research with BMSM that helped lead to the development of HPTN 073,
- Details about the HPTN 073 study, including more information about who will be eligible to enroll in the study and an overview of the research goals, and;
- A description of community engagement strategies and ongoing recruitment engagement efforts.